Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1ФГАОУ ВО «Российский университет дружбы народов», Москва, Россия; 2ГБУЗ «Детская городская клиническая больница им. З.А. Башляевой» Департамента здравоохранения г. Москвы, Москва, Россия anait_tamrazova@mail.ru
Список исп. литературыСкрыть список 1. Arock M, Valent P. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Expert Rev Hematol 2010; 3: 497–516. 2. Nettelship E, Tay W. Rare forms of urticarial. BMJ; 1869; 2: 323–30. 3. Sangster A. An anomalous mottled rash, accompanied by pruritus, factitious urticaria and pigmentation, ‘urticaria pigmentosa’ (?). Trans Clin Soc London 1878; 11: 161–3. 4. Ellis JM. Urticaria pigmentosa. A report of a case with autopsy. AMA Arch Pathol 1949; 48: 426–9. 5. Tamay Z, Ozceker D. Current approach to cutaneous mastocytosis in childhood. Turk Pediatri Ars 2016; 51 (3): 123–7. 6. Le M, Miedzybrodzki B, Olynych T et al. Natural history and treatment of cutaneous and systemic mastocytosis. Postgrad Med 2017; 129 (8): 896–901. 7. Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis. Immunol Allergy Clin North Am 2014; 34 (2): 283–95. 8. Потапенко В.Г., Скорюкова К.А. Мастоцитоз у детей и взрослых. Результаты анализа Российской группы пациентов. Клиническая патофизиология. 2017; 23 (3); 54–60. [Potapenko V.G., Skoriukova K.A. Mastotsitoz u detei i vzroslykh. Rezul'taty analiza Rossiiskoi gruppy patsientov. Klinicheskaia patofiziologiia. 2017; 23 (3); 54–60 (in Russian).] 9. Wilson T, Maric I, Simakova O et al. Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis. Haematologica 2011; 96 (3): 459–63. 10. Carter MC, Metcalfe DD. Paediatric mastocytosis. Arch Dis Child 2002; 86 (5): 315–19. 11. Цибулькина В.Н., Цибулькин Н.А. Патофизиология тучных клеток при мастоцитозе: значение в клинике и диагностике. Практическая медицина. 2016; 9 (101): 7–11. [Tsibul'kina V.N., Tsibul'kin N.A. Patofiziologiia tuchnykh kletok pri mastotsitoze: znachenie v klinike i diagnostike. Prakticheskaia meditsina. 2016; 9 (101): 7–11 (in Russian).] 12. Hartmann K, Escribano L, Grattan C et al. Сutaneous manifestations in mastocytosis: consensus report of the European Competence Network on Mastocytosis, the American Academy of Allergy, Asthma & Immunology, and the European Academy of Allergology and Clinical Immunology. J Allergy Clin Immunol 2016; 137 (1): 35–45. 13. Méni C, Bruneau J, Georgin-Lavialle S et al. Paediatric mastocytosis: a systematic review of 1747 cases. Br J Dermatol 2015; 172 (3): 642–51. 14. Arber DA, Orazi A, Hasserjian R et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127 (20): 2391–405. 15. Marrouche N, Grattan C. TMEP or not TMEP: that is the question. J Am Acad Dermatol 2014; 70 (3): 581–2. 16. Pardanani A., Teff eri A. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature. Curr Opin Hematol 2010; 17 (2): 125–32. 17. Valent P, Escribano L, Broesby-Olsen S et al. Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis. Allergy 2014; 69: 1267–74. 18. Uzzaman A, Maric I, Noel P et al. Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology. Pediatr Blood Cancer 2009; 53: 629–34. 19. Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis: a review of 180 patients. Isr Med Assoc J 2005; 7: 320–2. 20. Wiechers T, Rabenhorst A, Schick T et al. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis. J Allergy Clin Immunol 2015; 136 (6): 1581–90. 21. Castells M. Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations. Am J Clin Dermatol 2011; 12 (4): 259–70. 22. Torrelo A, Alvarez-Twose I, Escribano L. Childhood mastocytosis. Curr Opin Pediatr 2012; 24 (4): 480–6. 23. Bergström A, Rollman O, Emtestam L et al. Cutaneous mastocytosis – update and clinical guidelines. Lakartidningen 2018; Oct 22; 115. 24. Brockow K, Scott LM, Worobec AS et al. Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease. Arch Dermatol 2002; 138 (6): 785–90. 25. Broesby-Olsen S, Dybedal I, Gülen T et al. Multidisciplinary management of mastocytosis – Nordic expert group consensus. Acta Derm Venereol 2016; 96 (5): 602–12. 26. Lange M, Nedoszytko B, Gorska A et al. Mastocytosis in children and adults: clinical disease heterogeneity. Arch Med Sci 2012; 8: 533–41. 27. Болотная Л.А. Тучные клетки и мастоцитоз. Дерматологiя та венерологiя. 2016; 3 (73): 5–14. [Bolotnaia L.A. Tuchnye kletki i mastotsitoz. Dermatologiia ta venerologiia. 2016; 3 (73): 5–14 (in Russian).] 28. Matito A, Azaña JM, Torrelo A, Alvarez-Twose I. Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors. Immunol Allergy Clin North Am 2018; 38 (3): 351–63. 29. Alvarez-Twose I, Jara-Acevedo M, Morgado JM et al. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis. J Allergy Clin Immunol 2016; 137 (1): 168–78. 30. Carter MC, Clayton ST, Komarow HD, et al. Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis. J Allergy Clin Immunol 2015; 136 (6): 1673–9. 31. Middelkamp Hup MA, Heide R, Tank B et al. Comparison of mastocytosis with onset in children and adults. J Eur Acad Dermatol Venereol 2002; 16 (2): 115–20. 32. Barton J, Lavker RM, Schechter NM et al. Treatment of urticaria pigmentosa with corticosteroids. Arch Dermatol 1985; 121 (12): 1516–23. 33. Потапенко В.Г., Скорюкова К.А., Лисукова Е.В. и др. Мастоцитоз у детей: Характеристика группы 111 пациентов. Педиатрия. Журнал им. Г.Н. Сперанского. 2018; 97 (4): 135–40. [Potapenko V.G., Skoriukova K.A., Lisukova E.V. et al. Mastotsitoz u detei: Kharakteristika gruppy 111 patsientov. Pediatriia. Zhurnal im. G.N. Speranskogo. 2018; 97 (4): 135–40 (in Russian).] 34. Berezowska S, Flaig MJ, Ruеff F et al. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis. Mod Pathol 2014; 27 (1): 19–29. 35. Barnes M, Van L, DeLong L et al. Severity of cutaneous findings predict the presence of systemic symptoms in pediatric maculopapular cutaneous mastocytosis. Pediatr Dermatol 2014; 31 (3): 271–5. 36. Verma KK, Bhat R, Singh MK. Bullous mastocytosis treated with oral betamethasone therapy. Indian J Pediatr 2004; 71 (3): 261–3. 37. Patrizi A, Tabanelli M, Neri I et al. Topical corticosteroids versus “wait and see” in the management of solitary mastocytoma in pediatric patients: a long-term follow-up. Dermatol Ther 2015; 28 (2): 57–61. 38. Pyatilova P, Teplyuk N, Olisova O et al. Efficacy of PUVA in Russian patients with mastocytosis: a case series and review of literature. Int J Dermatol 2018; 57 (9): e59-e64. DOI: 10.1111/ijd.14103